STOCK TITAN

Piermont Valley Acquisition (CMCWF) SEC Filings

CMCWF OTC
Rhea-AI Summary

Piermont Valley Acquisition Corp (CMCAF) reported a net loss of $113,299 for the quarter ended September 30, 2026, compared with $108,103 a year earlier. For the six months, net loss was $118,701, versus $1,005,148 in 2025. Warrant-liability fair-value expense was $115,000 in the six-month period, compared with $1,001,244 a year earlier. Quarterly formation and operating costs were $20,461, versus $82,592.

At September 30, 2026, the Trust Account held $2,500,974, while cash outside it was $2,877. Sponsor Valleypark Road, LLC had $278,021 outstanding under its non-interest-bearing working-capital note, payable upon a business combination and convertible at the sponsor’s option into warrants at $1.50 per warrant if a combination closes. The proposed merger with Tigerless remains subject to shareholder, SEC, financing, listing and other closing conditions, and there is no assurance it will close. Shareholders extended the business-combination deadline to March 3, 2027. Nasdaq suspended and delisted the company’s securities on June 12, 2024, after it did not complete a combination within 36 months of the IPO registration statement’s effectiveness.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
-
Rhea-AI Summary

Piermont Valley Acquisition Corp. (CMCAF) seeks approval of its proposed combination with Tigerless Health; the accompanying prospectus covers 11,554,450 Pubco Class A shares, 22,400,000 Class B shares, 11,500,000 warrants and 11,500,000 underlying Class A shares. At closing, each PVAC ordinary share would convert into one generally nonvoting Pubco Class A share, and each public warrant would become a warrant to buy one such share at an $11.50 exercise price. Assuming no redemptions, Tigerless Health holders would receive 5,600,000 Class A and 22,400,000 Class B shares; PVAC holders would receive 5,954,450 Class A shares.

Zikang Wu is expected to hold all Pubco Class B shares, the voting class, and control Pubco’s voting power. Capstan Point, LLC committed to buy 5,000 Series A preferred shares for $5.0 million in two post-closing tranches: $3.5 million on the first business day and $1.5 million on the 90th business day, subject to the agreement’s conditions. The variable conversion price has a downward-resetting floor and may cause substantial dilution. Existing stockholders are to transfer 2,000,000 Pubco Class A shares to the PIPE investor as a closing fee, subject to a 4.99% beneficial-ownership limitation.

The virtual meeting is scheduled for December 9, 2026, to vote on the combination and related proposals; the board recommends voting “FOR.” The redemption price was approximately $12.72 per share as of October 30, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy
-
Rhea-AI Summary

Piermont Valley Acquisition Corp (symbol: CMCAF) is the issuer of record for a Form 8-K filing submitted to the SEC.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

Piermont Valley Acquisition Corp., a Cayman Islands SPAC, reported a small net loss of $5,402 for the quarter ended June 30, 2026, with minimal cash outside the trust of $2,875 and cash and cash equivalents in its trust account of $2,478,814 tied to 204,450 redeemable Class A shares.

The company remains a shell and has not generated operating revenue; income comes from trust investment and dividend income. Extensive prior redemptions have reduced the original $234.6 million trust to its current level. Working capital shows a deficit of $352,705, including a related-party note payable of $276,521.

Piermont Valley entered into a Merger Agreement with Tigerless Health, Inc. in April 2026, under which a new Nevada holding company, Pubco, is expected to become the public parent, with Tigerless shareholders expected to hold a majority and Tigerless’s founder eligible for up to 10,000,000 earn-out shares. Closing is subject to shareholder approvals, SEC effectiveness of a Form S-4, listing of Pubco shares and securing at least $5,000,000 of PIPE financing, for which no commitments yet exist.

The company’s securities were delisted from Nasdaq in June 2024 for not completing a business combination within 36 months. Management discloses substantial doubt about the company’s ability to continue as a going concern if a business combination is not completed by March 3, 2027 and additional financing is not obtained.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.00%
Tags
quarterly report
-
Rhea-AI Summary

Piermont Valley Acquisition Corp, a Cayman Islands SPAC, filed its annual report describing its status, risks and plans to complete a merger before March 3, 2027. The company has repeatedly extended its deadline and, after several large redemption rounds, now has 5,954,449 Class A shares and 1 Class B share outstanding.

The report highlights a pending business combination with Tigerless Health via a multi-step merger into a new Nevada holding company, where former Tigerless stockholders are expected to own a majority. As of March 31, 2026, the trust account is anticipated to be about $12.02 per public share, and if no deal is completed by the deadline the SPAC will liquidate and redeem public shares.

Terms include up to $100 million of stock-based earn-out for Tigerless holders tied to multi-year performance milestones and a targeted PIPE raise of at least $5 million, which is not yet committed. The filing also notes prior termination of a Lexasure transaction and the company’s 2024 delisting from Nasdaq after missing the 36‑month business combination window.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
annual report
-
Rhea-AI Summary

Tigerless Health, Inc., a New York-based Insurtech platform, has agreed to a definitive business combination with Piermont Valley Acquisition Corp., a publicly traded SPAC, valuing Tigerless Health at an enterprise value of approximately $280 million.

After closing, the combined company is expected to be renamed Tigerless AI Holdings, Inc. and listed on NASDAQ, with all existing Tigerless Health shareholders rolling 100% of their equity. The deal is intended to support continued investment in the company’s proprietary AI capabilities that help consumers understand and navigate insurance.

The boards of both companies have unanimously approved the transaction, which is expected to close in the second half of 2026, subject to shareholder and regulatory approvals and other customary closing conditions. Founder and CEO Zikang Wu and his management team are expected to continue leading the combined company.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
166.67%
Tags
current report

FAQ

How many Piermont Valley Acquisition (CMCWF) SEC filings are available on StockTitan?

StockTitan tracks 6 SEC filings for Piermont Valley Acquisition (CMCWF), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Piermont Valley Acquisition (CMCWF)?

The most recent SEC filing for Piermont Valley Acquisition (CMCWF) was filed on November 13, 2026.